Osteoarthritis is a degenerative joint condition, most commonly affecting the knee, in which cartilage breaks down and causes pain and reduced function. It drives demand for orthopedic, injectable, and device interventions — up to and including arthroplasty.
As a diagnosis, osteoarthritis is a claims-based anchor for identifying the providers and populations relevant to joint-pain products.
Osteoarthritis is a diagnosis-led targeting segment: rather than starting from a procedure, vendors start from the condition, identifying the providers who treat large osteoarthritis populations. This is ideal for injectables, braces, and early-intervention devices used before surgery.
Because osteoarthritis is captured in ICD-10 data, teams can quantify where joint-pain patients concentrate and which clinicians manage them — a foundation for both targeting and market sizing.
Osteoarthritis is a degenerative joint disease in which cartilage wears down, causing pain and stiffness — most commonly in the knees, hips, and hands. It's a leading driver of demand for orthopedic and pain-management interventions.
Osteoarthritis is a diagnosis-led segment: using ICD-10 data, teams identify providers treating large osteoarthritis populations and target them for relevant products like injectables, braces, or early-intervention devices, before patients progress to surgery.
ICD-10 targeting uses the diagnosis codes for osteoarthritis to find the providers and geographies with the highest concentration of affected patients. This pinpoints clinicians managing the relevant population rather than targeting an entire specialty.
Osteoarthritis is a primary reason patients eventually need arthroplasty (joint replacement). Targeting can begin at the diagnosis stage (osteoarthritis) for earlier interventions or at the procedure stage (arthroplasty) for surgical products.